US Stock MarketDetailed Quotes
YMAB Y-mAbs Therapeutics
- 13.740
- +0.420+3.15%
Close Aug 23 16:00 ET
- 13.740
- 0.0000.00%
Post 20:02 ET
612.39MMarket Cap-24535P/E (TTM)
13.880High13.320Low156.61KVolume13.440Open13.320Pre Close2.14MTurnover0.58%Turnover RatioLossP/E (Static)44.57MShares20.90052wk High6.42P/B370.90MFloat Cap4.69052wk Low--Dividend TTM26.99MShs Float55.215Historical High--Div YieldTTM4.20%Amplitude2.700Historical Low13.658Avg Price1Lot Size
Y-mAbs Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 106.29%298K | 73.51%-3.48M | 64.13%-27.23M | 7.22%-8.04M | 93.04%-1.34M | 79.51%-4.73M | 47.35%-13.12M | 25.97%-75.92M | 74.42%-8.66M | -6.41%-19.24M |
| Net income from continuing operations | -46.76%-9.25M | -3.74%-6.63M | 77.58%-21.43M | -185.39%-988K | 71.86%-7.75M | 84.68%-6.3M | 77.23%-6.39M | -72.90%-95.57M | 103.14%1.16M | 4.62%-27.53M |
| Operating gains losses | 172.96%232K | 207.89%492K | -135.20%-1.26M | -635.54%-890K | -79.39%405K | -122.36%-318K | -246.62%-456K | 88.56%3.58M | -110.56%-121K | 725.63%1.97M |
| Depreciation and amortization | -31.70%153K | -12.64%159K | -12.40%735K | -30.00%161K | -25.66%168K | 19.15%224K | -6.67%182K | 7.29%839K | -20.96%230K | 55.86%226K |
| Change In working capital | 392.89%5.72M | 88.57%-1.35M | -90.28%-19.73M | 29.87%-9.44M | 24.18%3.43M | -170.09%-1.95M | -379.38%-11.76M | -42.38%-10.37M | -306.15%-13.46M | -49.82%2.76M |
| -Change in receivables | -4,137.50%-17.63M | 130.24%1.87M | -105.91%-9.92M | -9.15%-3.58M | 111.94%244K | -119.66%-416K | -282.82%-6.17M | 37.51%-4.82M | -632.14%-3.28M | -263.05%-2.04M |
| -Change in inventory | -101.33%-50K | -50.82%-3.38M | 237.56%1.64M | 545.22%2.05M | -448.91%-1.93M | 411.61%3.76M | -2,851.32%-2.24M | 78.41%-1.19M | 36.55%-460K | 157.08%552K |
| -Change in payables and accrued expense | 1,860.19%24.45M | -25.37%-2.62M | -211.86%-4.65M | 65.77%-2.18M | -58.20%1M | -247.92%-1.39M | -236.36%-2.09M | -126.82%-1.49M | -769.30%-6.37M | -46.91%2.4M |
| -Change in other current assets | 73.18%-1.05M | 321.33%2.79M | -136.76%-6.8M | -70.62%-5.73M | 122.08%4.1M | -516.08%-3.91M | 45.13%-1.26M | -863.30%-2.87M | -8.60%-3.36M | 168.60%1.85M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 106.29%298K | 73.51%-3.48M | 64.13%-27.23M | 7.22%-8.04M | 93.04%-1.34M | 79.51%-4.73M | 47.35%-13.12M | 25.97%-75.92M | 74.42%-8.66M | -6.41%-19.24M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | --0 | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 1.76M | 588K | 19.05%100K | 100K | 0 | 0 | 0 | -99.92%84K | 0 | -79.03%52K |
| Proceeds from stock option exercised by employees | --1.76M | --588K | 19.05%100K | --100K | --0 | --0 | --0 | -85.74%84K | --0 | -79.03%52K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --1.76M | --588K | 19.05%100K | --100K | --0 | --0 | --0 | -99.92%84K | --0 | -79.03%52K |
| Net cash flow | ||||||||||
| Beginning cash position | -18.22%75.75M | -25.65%78.64M | -41.75%105.76M | -24.41%86.57M | -34.23%87.91M | -40.90%92.63M | -41.75%105.76M | 58.39%181.56M | -46.91%114.53M | -42.78%133.67M |
| Current changes in cash | 143.43%2.06M | 77.99%-2.89M | 64.22%-27.13M | 8.37%-7.94M | 93.03%-1.34M | 79.51%-4.73M | 47.28%-13.12M | -213.53%-75.84M | 74.69%-8.66M | -7.17%-19.18M |
| Effect of exchange rate changes | -92.86%1K | 111.11%1K | -80.00%7K | 101.94%2K | --0 | -65.85%14K | -116.98%-9K | -72.87%35K | -298.08%-103K | 4.76%44K |
| End cash Position | -11.49%77.81M | -18.22%75.75M | -25.65%78.64M | -25.65%78.64M | -24.41%86.57M | -34.23%87.91M | -40.90%92.63M | -41.75%105.76M | -41.75%105.76M | -46.91%114.53M |
| Free cash flow | 106.29%298K | 73.51%-3.48M | 64.13%-27.23M | 7.22%-8.04M | 93.04%-1.34M | 79.51%-4.73M | 47.35%-13.12M | 26.66%-75.92M | 74.76%-8.66M | -6.00%-19.24M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg